Patents by Inventor Peter E. Daddona

Peter E. Daddona has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11660265
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods for treating migraine by administering zolmitriptan using an adhesive dermally-applied microarray (ADAM) resulting in rapid and durable pain relief, pain freedom and reduction in most bothersome migraine-associated symptoms (MBS), or a combination thereof.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: May 30, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • Publication number: 20210275445
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Patent number: 11058630
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: July 13, 2021
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20200000712
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 2, 2020
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • Publication number: 20180153799
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: January 29, 2018
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20180153798
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: October 9, 2017
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Patent number: 9918932
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: March 20, 2018
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Patent number: 9782344
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: October 10, 2017
    Assignee: ZP OPCO, INC.
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Publication number: 20170239174
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: February 21, 2017
    Publication date: August 24, 2017
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Patent number: 9295714
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: March 29, 2016
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Yuh-Fun Maa, Peter E. Daddona, Marika Kamberi
  • Publication number: 20160051467
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: November 2, 2015
    Publication date: February 25, 2016
    Inventors: Mahmoud AMERI, Peter E. DADDONA, Yi AO
  • Patent number: 9173924
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: November 3, 2015
    Assignee: ZP OPCO, INC.
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Publication number: 20150057605
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: August 22, 2014
    Publication date: February 26, 2015
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Publication number: 20150038897
    Abstract: A low-profile applicator, and a method of manufacturing and use thereof, for impacting microneedles against the stratum corneum of a person having a housing, a diaphragm member having the microneedles, a folding member having interlinking members that hinge-ably rotate with a force member, operatively attached thereto, between a resting position and an extended position. The folding member translates energy stored within the force member when release while retaining the force member in an energized state when in the resting position.
    Type: Application
    Filed: July 30, 2014
    Publication date: February 5, 2015
    Inventors: Peter E. Daddona, Cedric Wright, Matt Vargas, Vivian Lee, Jessica Heasley
  • Publication number: 20140212413
    Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-? (TNF?) and are useful in vivo diagnosis and therapy of a number of TNF?-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
    Type: Application
    Filed: January 17, 2014
    Publication date: July 31, 2014
    Applicants: New York University, Janssen Biotech, Inc.
    Inventors: Junming Le, Jan T. Vilcek, Peter E. Daddona, John Ghrayeb, David M. Knight, Scott A. Siegel
  • Patent number: 8663155
    Abstract: A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: March 4, 2014
    Assignee: Alza Corporation
    Inventors: Michel J. N. Cormier, Wendy A. Young, Kofi Nyam, Peter E. Daddona, Wei-Qi Lin
  • Patent number: 8633159
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: January 21, 2014
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Yuh-Fun Maa, Marika Kamberi, Peter E. Daddona
  • Patent number: 8361022
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: January 29, 2013
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Yuh-Fun Maa, Peter E. Daddona, Marika Kamberl
  • Publication number: 20110195063
    Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-? (TNF?) and are useful in vivo diagnosis and therapy of a number of TNF?-mediated pathologies and conditions, including ankylosing spondylitis, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
    Type: Application
    Filed: September 17, 2010
    Publication date: August 11, 2011
    Applicants: Centocor, Inc., New York University
    Inventors: Junming Le, Jan T. Vilcek, Peter E. Daddona, John Ghrayeb, David M. Knight, Scott A. Siegel, David J. Shealy
  • Patent number: 7963935
    Abstract: The device including a plurality of stratum corneum-piercing microprojections, and a solid coating disposed upon the microprojections, wherein the solid coating includes at least one beneficial agent and a biocompatible carrier is provided. The device is applied to the skin of a living animal (e.g., a human), causing the microprojections to pierce the stratum corneum and deliver an effective dose of the agent to the animal.
    Type: Grant
    Filed: April 20, 2002
    Date of Patent: June 21, 2011
    Assignee: Alza Corporation
    Inventors: Michel J. N. Cormier, Wendy A. Young, Juanita A. Johnson, Peter E. Daddona